Similar articles

Abstract: The close phylogenetic relationship between humans and non-human primates makes non-human primates an irreplaceable model for the study of human infectious diseases. In this study, we describe the development of a large-scale automatic multi-functional isolation chamber for use with medium-sized laboratory animals carrying infectious diseases. The isolation chamber, including the transfer chain, disinfection chain, negative air pressure isolation system, animal welfare system, and the automated system, is designed to meet all biological safety standards. To create an internal chamber environment that is completely isolated from the exterior, variable frequency drive blowers are used in the air-intake and air-exhaust system, precisely controlling the filtered air flow and providing an air-barrier protection. A double door transfer port is used to transfer material between the interior of the isolation chamber and the outside. A peracetic acid sterilizer and its associated pipeline allow for complete disinfection of the isolation chamber. All of the isolation chamber parameters can be automatically controlled by a programmable computerized menu, allowing for work with different animals in different-sized cages depending on the research project. The large-scale multi-functional isolation chamber provides a useful and safe system for working with infectious medium-sized laboratory animals in high-level bio-safety laboratories.

[1]Allen, J.R., Burgess, M., Aiken, S.C., 2009. Container Lid Gasket Protective Strip for Double Door Transfer System. US Patent Pub. 0212054 A1.

[2]Clough, G., Wallace, J., Gamble, M.R., Merryweather, E.R., Bailey, E., 1995. A positive, individually ventilated caging system: a local barrier system to protect both animals and personnel. Lab. Anim., 29(2):139-151.

[3]Conly, J., Johnston, B., 2008. The infectious diseases consequences of monkey business. Can. J. Infect. Dis. Med. Microbiol., 19(1):12-14.

[4]Fouchier, R.A., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G.J., van den Hoogen, B.G., Peiris, M., Lim, W., Stöhr, K., Osterhaus, A.D., 2003. Aetiology: Koch’s postulates fulfilled for SARS virus. Nature, 423(6937):240.

[5]Hillman, P., Gebremedhin, K., Warner, R., 1992. Ventilation system to minimize airborne bacteria, dust, humidity, and ammonia in calf nurseries. J. Dairy. Sci., 75(5):1305-1312.

[6]Huang, R., 2005. Isolator of Using Negative Pressure for Big Animals. CN Patent Publication 1625942A (in Chinese).

[7]Hurni, H., 1981. SPF-cat breeding. Z. Versuchstierkd., 23(2):102-121.

[8]Institute of Laboratory Animal Resources Commission on Life Sciences, National Research Council, 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.

[9]ISO 10648-1:1997. Containment Enclosures—Part 1: Design Principles. International Organization for Standardization, Geneva.

[10]ISO 14644-7:2004. Cleanrooms and Associated Controlled Environments—Part 7: Separative Devices (Clean Air Hoods, Gloveboxes, Isolators and Minienvironments). International Organization for Standardization, Geneva.

[11]Kruse, R.H., Puckett, W.H., Richardson, J.H., 1991. Biological safety cabinetry. Clin. Microbiol. Rev., 4(2):207-241.

[12]Michael, A., Szatmary, F.T., Worth, T.X., 2004. Rapid Transfer Port. US Patent 6779567 B1.

[13]Pan, X., Sun, Y., 2004. Expression of SARS-CoV spike protein functional receptor ACE2 in human cornea and conjunctiva tissues. High Technol. Lett., 10(Suppl.):273-277.

[14]Runkle, R.S., Allendale, N.J., Marsh, R.C., Albuquerque, N.M., 1969. Unit for Providing Environmental Control of Animals. US Patent 3630174.

[15]Sawyer, J., Bennett, A., Haines, V., Elton, E., Crago, K., Speight, S., 2007. The effect of microbiological containment systems on dexterity. J. Occup. Environ. Hyg., 4(3):166-173.

[16]Tattershall, S.F., 2006. Enclosure for Handling Hazardous Material. US Patent 7077486 B2.

[17]Tauraso, N.M., Norris, G.F., Sorg, T.J., Cook, R.O., Myers, M.L., Trimmer, R., 1969. Negative-pressure isolator for work with hazardous infectious agents in monkeys. Appl. Microbiol., 18(2):294-297.

[18]Tsai, C., Caillet, C., Hu, H., Zhou, F., Ding, H., Zhang, G., Zhou, B., Wang, S., Lu, S., Buchy, P., et al., 2009. Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase. Vaccine, 27(48):6777-6790.

[19]Wathes, C.M., Johnson, H.E., 1991. Physical protection against airborne pathogens and pollutants by a novel animal isolator in a level 3 containment laboratory. Epidemiol. Infect., 107(1):157-170.

[20]World Health Organization, 2004. Laboratory Biosafety Manual, 3rd Ed. World Health Organization, Geneva.